Wu Xiaobin

Filings by Wu Xiaobin span 2 companies, the busiest being BeOne Medicines Ltd. and Clover Biopharmaceuticals, Ltd. - B. Between 3 May 2021 and 25 August 2026, the trades on record add up to 42 filings.

On the open market, the record shows 1 purchase and 28 sales worth €8.2M. The totals do not cover 9 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 9 share grants and 3 option exercises. Since January 2026: 1 purchase and 6 sales on the market.

The record was last updated on 27 August 2026 with an open-market sale (€91k) in BeOne Medicines Ltd. The most recent open-market purchase was published on 1 April 2026, 201 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.